v3.26.1
Organization , Description of Business and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Third-party Payers as a Percentage of Total
The Company’s total third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:
 
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Medicare33 %33 %33 %33 %
UnitedHealthcare13 %14 %13 %13 %
46 %47 %46 %46 %
The Company's significant third-party payers in excess of 10% of total accounts receivable and their related accounts receivable balance as a percentage of total accounts receivable were as follows:
 
June 30, 2026December 31, 2025
Medicare19 %20 %
UnitedHealthcare17 %14 %
Schedule of Revenue Revenue included in biopharmaceutical and other revenue for the three and six months ended June 30, 2026 and 2025 was as follows (in thousands of dollars):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Biopharmaceutical revenue$802 $2,630 $1,103 $4,927 
Contract manufacturing and testing— 1,673 — 2,960 
Total$802 $4,303 $1,103 $7,887